HAL
48
-3
URI
60
-6
SYF
86
-6
AON
54
2
URBN
48
-6
LH
40
-5
SWKS
38
-2
HCP
56
-8
BK
74
3
VZ
44
4
ECL
55
-2
EA
60
-5
STI
45
26
O
17
-13
AXP
67
-2
EW
32
3
JNPR
50
-6
HIG
66
2
CTSH
60
-3
DRI
50
-3
HAL
48
-3
URI
60
-6
SYF
86
-6
AON
54
2
URBN
48
-6
LH
40
-5
SWKS
38
-2
HCP
56
-8
BK
74
3
VZ
44
4
ECL
55
-2
EA
60
-5
STI
45
26
O
17
-13
AXP
67
-2
EW
32
3
JNPR
50
-6
HIG
66
2
CTSH
60
-3
DRI
50
-3
Financhill
Back

Broadstone Net Lease Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
62

BNL
Broadstone Net Lease

Last Price:
17.21
Seasonality Move:
2.39%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
62
Broadstone Net Lease (BNL) is a Buy

Is Broadstone Net Lease a Buy, Sell or Hold?

  • The current Broadstone Net Lease [BNL] share price is $17.20. The Score for BNL is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • BNL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BNL Stock Price Chart

What is Broadstone Net Lease's stock price today?

  • The Broadstone Net Lease share price today is $17.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNL is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BNL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 37.21 Sell
Chaikin Money Flow: 676898 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.37 - 18.35) Sell
Bollinger Bands (100): (16.88 - 18.56) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

BNL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.36 Sell
20-day SMA: 17.7 Sell
50-day SMA: 18.19 Sell
200-day SMA: 16.44 Buy
8-day EMA: 17.3 Sell
20-day EMA: 17.63 Sell
50-day EMA: 17.85 Sell
200-day EMA: 17 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Broadstone Net Lease Earnings Growth & BNL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.05 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Broadstone Net Lease Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):